MarketPeel
Insider Trading Intelligence
Pricing
…
PL

Polaris Venture Partners V, L.p.

LYRA
10% OWNER · LYRA THERAPEUTICS, INC. · CIK 0001439590
FILING MIX · LIFETIME27%/73%
BUYS
12
SELLS
32
TOTAL VALUE
$1.31M
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
20,701
AVG SELL PX
$16.00
TRADE KIND
SHOWING 44 / 44
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Polaris Venture Partners V, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+50.00%-2.40%+0.16%-2.56%-2.56%—
14d8+50.00%-13.27%+2.02%-15.29%-15.29%—
30d8+50.00%-3.90%+8.79%-12.70%-12.70%—
60d8+50.00%-33.27%+9.58%-42.85%-42.85%—
90d8+50.00%-17.84%+15.39%-33.23%-33.23%—
180d8+50.00%-34.23%+16.35%-50.59%-50.59%—
1y8+50.00%-49.31%+47.60%-96.91%-96.91%—
2y8+50.00%-63.48%+48.85%-112.34%-112.34%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LYRA · 20,701 shares · as of May 5, 2020
0265,565531,130796,6941,062,259SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
FLOW · 12 buys / 32 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
LYRA
LYRA THERAPEUTICS, INC.
SALE
9,334$16.00$149.3K1,001,951May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
60,308$16.00$964.9K1,062,259May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
17,304——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
58,980——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
17,304$8.63$149.3K1,011,285May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
6,807——6,807May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
43,966——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
64,183——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
64$16.00$1.0K6,861May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
182$16.00$2.9K19,525May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
22,580——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
173——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
993,981——993,981May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
94$16.00$1.5K10,015May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
62,687——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
603$16.00$9.6K10,618May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
42,941——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
122,177——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
13,625——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
173$8.63$1.5K10,109May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
9,936——9,936May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
19,370——19,370May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
38,765——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
76,934——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
52,700——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
125,094——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
1,988,991——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
8,610,081——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
7,693,406——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
118$8.63$1.0K6,925May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
6,268,687——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
118——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
86,101——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
19,890——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
64,237——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
6,418,387——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
3,296,014——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
149,944——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
167,809——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
32,961——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
337$8.63$2.9K19,707May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
SALE
337——0May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
413$16.00$6.6K7,274May 5, 2020May 6, 2020 ↗
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
1,176$16.00$18.8K20,701May 5, 2020May 6, 2020 ↗
Other insiders · LYRA
Loading peer insiders…
About this filer
CIK 0001439590
ROLE
10% Owner
PRIMARY
LYRA
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001439590DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback